| WARRANTS |
12. WARRANTS
The following is a continuity schedule of the Company’s common share purchase warrants:
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
Average
|
|
|
|
Number of
|
|
Exercise Price
|
|
|
|
Warrants
|
|
($)
|
|
Outstanding and exercisable, March 31, 2018 and September 30, 2018
|
|
365,974
|
|
53.19
|
|
Issued in connection with anti-dilution provision connected warrant transaction
|
|
67,952
|
|
55.71
|
|
Issued in connection with anti-dilution provision connected warrant transaction
|
|
6,305
|
|
34.50
|
|
Issued in connection with anti-dilution provision connected warrant transaction
|
|
52,590
|
|
38.91
|
|
Expired
|
|
(204,304)
|
|
(51.85)
|
|
Outstanding and exercisable, March 31, 2019
|
|
288,517
|
|
40.27
|
|
Expired
|
|
(163,483)
|
|
(38.91)
|
|
Outstanding and exercisable, September 30, 2019
|
|
125,034
|
|
20.07
|
During the six months ended September 30, 2019, 163,483 warrants expired in accordance with their terms (September 30, 2018 – Nil)
Common share purchase warrants
The following is a summary of common share purchase warrants outstanding as of September 30, 2019.
|
|
|
|
|
|
|
Exercise
|
|
Number of
|
|
|
|
Price ($)
|
|
Warrants
|
|
Expiry Date
|
|
90.00
|
|
15,658
|
|
March 31, 2023
|
|
37.50
|
|
2,667
|
|
June 27, 2020
|
|
9.375
|
|
64,025
|
|
August 14, 2022
|
|
9.375
|
|
42,684
|
|
March 31, 2022
|
|
|
|
125,034
|
|
|
The weighted-average remaining contractual term of the outstanding warrants was 2.82 years (March 31, 2019 – 1.51 years).
|